Edition:
United States

AC Immune SA (ACIU.OQ)

ACIU.OQ on NASDAQ Stock Exchange Global Market

12.63USD
15 Dec 2017
Change (% chg)

$0.33 (+2.68%)
Prev Close
$12.30
Open
$12.33
Day's High
$12.90
Day's Low
$12.33
Volume
21,475
Avg. Vol
26,761
52-wk High
$14.78
52-wk Low
$6.24

Select another date:

Mon, Nov 13 2017

BRIEF-AC Immune SA reports quarterly ‍loss per share CHF 0.15

* AC Immune SA reports third quarter 2017 financial results and corporate update

BRIEF-AC Immune SA to receive milestone payment for anti-tau antibody moving into phase 2 trial for alzheimer's disease

* AC Immune SA to receive milestone payment for anti-tau antibody moving into phase 2 trial for Alzheimer's Disease

BRIEF-AC Immune to get milestone payment for Alzheimer drug

* Says to receive milestone payment for anti-tau antibody moving into phase 2 trial for Alzheimer's disease ‍​

BRIEF-AC Immune to present at two investor conferences and provide scientific updates at CTAD conference

* AC Immune to present at two investor conferences and provide scientific updates at CTAD conference Source text for Eikon: Further company coverage:

BRIEF-AC Immune completes recruitment for low-dose cohort in world's first clinical trial for Anti-Abeta Vaccine

* AC Immune completes recruitment for low-dose Cohort in world's first clinical trial for Anti-Abeta Vaccine targeting alzheimer's disease-like characteristics in individuals with down syndrome Source text for Eikon: Further company coverage:

BRIEF-AC Immune reports Q2 ‍loss per share CHF 0.22​

* Q2 earnings per share view chf -0.16 -- Thomson Reuters I/B/E/S

Select another date: